Latest News
Keep up to date with all our latest investments, service offerings and news items.
-
-
February 26, 2025
Almac Pharma Services expands with exciting career opportunities
-
October 28, 2024
Almac Pharma Services announces recruitment event following major expansion at Craigavon HQ
-
October 1, 2024
Almac Group announces £11m investment to expand global analytical services
-
September 30, 2024
Almac Pharma Services Appoints New VP Finance
-
August 30, 2024
Almac Pharma Services Joins European Paediatric Formulation Initiative (EuPFI)
-
July 23, 2024
Almac Pharma Services Announces Successful FDA Inspection at Charnwood, UK Facilities
-
June 18, 2024
Almac Pharma Services Supports Rapid Launch of BioLineRx’s APHEXDA® (motixafortide)
-
June 4, 2024
Almac Pharma Services Appoints New VP of Business Development
-
April 30, 2024
Almac Pharma Services Supports Industry Consortium to Address Titanium Dioxide Alternative Challenge
-
April 22, 2024
Amicus Therapeutics Inc and Almac Pharma Services Mark 15-year Strategic Partnership with Patient Advocacy Event
-
April 4, 2024
Almac Pharma Services Appoints New Director of Manufacturing Science and Technology
-
March 20, 2024
Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
-
March 12, 2024
Almac Group Awarded six 2024 CDMO Leadership Awards
-
March 6, 2024
Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity
-
February 12, 2024
Almac Pharma Services Renew HPRA GMP Certification for European Facility
-
November 14, 2023
Almac Pharma Services Receives Brazilian ANVISA GMP Certification for US Facility
-
October 19, 2023
Almac Group releases details of £80 million expansion in Northern Ireland
-
March 24, 2023
Technical Quality Team Leaders Graduate with Masters in Pharmaceutical Validation Technology
-
February 21, 2023
Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories
-
February 14, 2023
Almac Pharma Services and Provention Bio, Inc Celebrate Rapid Launch of TZIELD™ (teplizumab-mzwv)
-
January 23, 2023
Almac Pharma Services Announces Two Vice President Appointments
-
January 12, 2023
Almac Pharma Services Recruiting Senior Operators in Charnwood
-
December 13, 2022
Almac Pharma Services Supports Rapid Launch of Provention Bio, Inc.’s Treatment TZIELD™ (teplizumab-mzwv)
-
October 17, 2022
Almac Pharma Services Supports Packaging and Supply of PTC Therapeutics’ Gene Therapy Upstaza™ for EU Launch
-
October 4, 2022
Almac Group Announces New COO and Appoints New Almac Pharma Services MD
-
March 22, 2022
Almac Group Clinical Supply and Commercial Solutions Support Agios’ Road to FDA Approval
-
March 14, 2022
Almac Pharma Services Expands its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products
-
February 1, 2022
Almac Group Recognised in Life Science Leader CMO Awards for the Eighth Time
-
August 5, 2019
Almac Group to Host EU Product Launch Workshop Series in California and Washington States
-
March 26, 2019
Almac Group Recognised with Six Life Science Leader CMO Awards
-
October 2, 2018
Almac Group Announces Successful HPRA Inspection at its European Campus
-
July 25, 2018
Almac Group Appoints Three Vice Presidents
-
April 16, 2018
Almac Group Expands US Specialised Commercial Packaging Capabilities
-
January 18, 2018
Almac Group announces further expansion at its European Campus in Dundalk
-
October 23, 2017
Almac Group Announces Successful MHRA Inspection at Charnwood Facilities
-
June 30, 2017
Petya ransomware attack – Almac update
-
March 15, 2017
Almac to Exclusively Share Global Expertise in EU Product Launch Workshop
-
November 14, 2016
Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations
-
August 2, 2016
Almac Group’s Integrated Development to Commercialisation Services Support Amicus Therapeutics’ First Commercial Orphan Drug Product
-
July 14, 2016
Almac Group’s Rapid Launch Services Support U.S. Approval of Intercept Pharmaceutical’s First Commercial Orphan Drug Product
-
April 25, 2016
Almac Group Launches US Serialisation Solution in Partnership with Optel Vision
-
March 23, 2016
Almac Wins Three CMO Leadership Awards
-
October 7, 2015
Almac Group Addresses Industry Demand for Multiparticulate Drug Products with Scalable Fluid Bed and Encapsulation Technologies
-
September 9, 2015
Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product
-
November 18, 2013
Almac Further Enhance 3rd Party Logistics Commercial Support Services for Niche / Orphan Drugs
-
February 6, 2013
Almac launches US commercial packaging operations with successful FDA inspection and new client partnership
-
October 3, 2012
Almac expands UK commercial capacity with the acquisition of new blistering technology
-
May 1, 2012
Almac installs Uhlmann Blister Line in new US Commercial Packaging Facility
-
March 7, 2012
Almac expands in US with addition of Commercial Packaging facility in Audubon
-
February 28, 2012
Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment
-
November 21, 2011
Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany
-
March 25, 2011
Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products
-
November 26, 2010
Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe
-
June 14, 2010
Almac completes £2 million client sponsored investment expanding commercial sacheting capacity
-
April 19, 2010
Almac completes its expansion plan to Pharma Services facilities
-
October 15, 2009
Almac Announce Potent Containment Capabilities
-
October 14, 2009
Almac Extends Commercial Support Services to add Third Party Logistics “3PL”
-
June 30, 2009
Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities
-
June 2, 2009
Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules
-
February 5, 2009
Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG
-
March 20, 2008
Almac Pharma Services Expands it Commercial Support Capability
-
March 17, 2008
Almac appoints new VP Commercial Operations for Pharma Services